Skip to main content
British Journal of Pharmacology logoLink to British Journal of Pharmacology
letter
. 1973 Feb;47(2):431–433. doi: 10.1111/j.1476-5381.1973.tb08343.x

Action of botulinum toxin on transmission from sympathetic nerves to the vas deferens

Mollie E Holman, N C Spitzer
PMCID: PMC1776555  PMID: 4352870

Abstract

Botulinum toxin (Type A) depressed or abolished transmission from postganglionic nerves to smooth muscle of isolated preparations of guinea-pig and mouse vas deferens. The time course of blockade was 2 to 6 times slower than that observed with the same concentration of the same batch of toxin on the rat diaphragm. Spontaneous excitatory junction potentials were still observed after 7 h exposure, indicating that the smooth muscle membrane was still able to respond to noradrenaline. Depression of transmission is probably due to a presynaptic action of unknown nature.

Full text

PDF
431

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. AMBACHE N. A further survey of the action of Clostridium botulinum toxin upon different types of autonomic nerve fibre. J Physiol. 1951 Mar;113(1):1–17. doi: 10.1113/jphysiol.1951.sp004551. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Ambache N. The peripheral action of Cl. botulinum toxin. J Physiol. 1949 Mar 15;108(2):127–141. [PMC free article] [PubMed] [Google Scholar]
  3. BROOKS V. B. An intracellular study of the action of repetitive nerve volleys and of botulinum toxin on miniature end-plate potentials. J Physiol. 1956 Nov 28;134(2):264–277. doi: 10.1113/jphysiol.1956.sp005642. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. BURNSTOCK G., HOLMAN M. E. The transmission of excitation from autonomic nerve to smooth muscle. J Physiol. 1961 Jan;155:115–133. doi: 10.1113/jphysiol.1961.sp006617. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Farnebo L. O., Malamfors T. 3 H-noradrenaline release and mechanical response in the field stimulated mouse vas deferens. Acta Physiol Scand Suppl. 1971;371:1–18. doi: 10.1111/j.1748-1716.1971.tb05210.x. [DOI] [PubMed] [Google Scholar]
  6. Harris A. J., Miledi R. The effect of type D botulinum toxin on frog neuromuscular junctions. J Physiol. 1971 Sep;217(2):497–515. doi: 10.1113/jphysiol.1971.sp009582. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Rand M. J., Whaler B. C. Impairment of sympathetic transmission by botulinum toxin. Nature. 1965 May 8;206(984):588–591. doi: 10.1038/206588a0. [DOI] [PubMed] [Google Scholar]
  8. Spitzer N. Miniature end-plate potentials at mammalian neuromuscular junctions poisoned by botulinum toxin. Nat New Biol. 1972 May 3;237(70):26–27. doi: 10.1038/newbio237026a0. [DOI] [PubMed] [Google Scholar]
  9. Westwood D. A., Whaler B. C. Postganglionic paralysis of the guinea-pig hypogastric nerve-vas deferens preparation by Clostridium botulinum type D toxin. Br J Pharmacol Chemother. 1968 May;33(1):21–31. doi: 10.1111/j.1476-5381.1968.tb00470.x. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES